160 related articles for article (PubMed ID: 8468595)
1. Regulation of membrane-mediated chronic muscle degeneration in dystrophic hamsters by calcium-channel blockers: diltiazem, nifedipine and verapamil.
Johnson PL; Bhattacharya SK
J Neurol Sci; 1993 Mar; 115(1):76-90. PubMed ID: 8468595
[TBL] [Abstract][Full Text] [Related]
2. Reversal of impaired oxidative phosphorylation and calcium overloading in the skeletal muscle mitochondria of CHF-146 dystrophic hamsters.
Bhattacharya SK; Johnson PL; Thakar JH
Mol Chem Neuropathol; 1998 May; 34(1):53-77. PubMed ID: 9778646
[TBL] [Abstract][Full Text] [Related]
3. The effects of diltiazem in dystrophic hamsters.
Bhattacharya SK; Palmieri GM; Bertorini TE; Nutting DF
Muscle Nerve; 1982 Jan; 5(1):73-8. PubMed ID: 7057811
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic, biochemical, and morphologic abnormalities in dystrophic hamsters with cardiomyopathy.
Bhattacharya SK; Crawford AJ; Pate JW
Muscle Nerve; 1987 Feb; 10(2):168-76. PubMed ID: 2950321
[TBL] [Abstract][Full Text] [Related]
5. Reduced sarcolemmal dystrophin distribution and upregulation of utrophin in the cardiac and skeletal muscles of CHF-146 dystrophic hamsters.
Bhattacharya SK; Johnson PL; Li HJ; Handa RK; Adamec TA
Mol Chem Neuropathol; 1997 Jun; 31(2):187-206. PubMed ID: 9376024
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris.
Palmieri GM; Nutting DF; Bhattacharya SK; Bertorini TE; Williams JC
J Clin Invest; 1981 Sep; 68(3):646-54. PubMed ID: 7276164
[TBL] [Abstract][Full Text] [Related]
7. Reversal of impaired oxidative phosphorylation and calcium overloading in the in vitro cardiac mitochondria of CHF-146 dystrophic hamsters with hereditary muscular dystrophy.
Bhattacharya SK; Johnson PL; Thakar JH
J Neurol Sci; 1993 Dec; 120(2):180-6. PubMed ID: 8138808
[TBL] [Abstract][Full Text] [Related]
8. Excessive intracellular zinc accumulation in cardiac and skeletal muscles of dystrophic hamsters.
Crawford AJ; Bhattacharya SK
Exp Neurol; 1987 Feb; 95(2):265-76. PubMed ID: 3803514
[TBL] [Abstract][Full Text] [Related]
9. Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability.
Matsumura CY; Pertille A; Albuquerque TC; Santo Neto H; Marques MJ
Muscle Nerve; 2009 Feb; 39(2):167-76. PubMed ID: 19145649
[TBL] [Abstract][Full Text] [Related]
10. Differential myolysis of myocardium and skeletal muscle in hamsters with dilated cardiomyopathy: beneficial protective effect of diltiazem.
Kato Y; Iwase M; Takagi K; Nishizawa T; Kanazawa H; Matsushita A; Umeda H; Izawa H; Noda A; Koike Y; Nagata K; Yokota M
Circ J; 2006 Nov; 70(11):1497-502. PubMed ID: 17062977
[TBL] [Abstract][Full Text] [Related]
11. Effects of calcium antagonists on insulin-mediated glucose metabolism in skeletal muscle.
Foot EA; Leighton B
Diabetes; 1994 Jan; 43(1):73-9. PubMed ID: 8262320
[TBL] [Abstract][Full Text] [Related]
12. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
13. The effect of DDB on dystrophic hamsters: an in vivo and in vitro study.
Shen DG; Araki M; Higuchi I; Matsumoto K; Tamai M; Liu KT; Sugita H
Muscle Nerve; 1987 Jun; 10(5):391-6. PubMed ID: 3614253
[TBL] [Abstract][Full Text] [Related]
14. Effects of cold acclimation in dystrophic hamsters: reduction of heart necrosis.
Desautels M; Dulos RA
Am J Physiol; 1986 Feb; 250(2 Pt 2):R167-74. PubMed ID: 3946635
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence of abnormal mechanical and oxidative functions in the exercised muscle of dystrophic hamsters by 31P-NMR.
Le Rumeur E; Le Tallec N; Lewa CJ; Ravalec X; de Certaines JD
J Neurol Sci; 1995 Nov; 133(1-2):16-23. PubMed ID: 8583220
[TBL] [Abstract][Full Text] [Related]
16. Differences in enzyme efflux from dystrophic mouse skeletal muscle and heart.
Morgan J; Bozyk ME; Bittner S; Cohen L
Res Commun Chem Pathol Pharmacol; 1980 Dec; 30(3):555-76. PubMed ID: 7255864
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.
Grover GJ; Sleph PG
J Cardiovasc Pharmacol; 1989 Aug; 14(2):331-40. PubMed ID: 2476610
[TBL] [Abstract][Full Text] [Related]
18. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
[TBL] [Abstract][Full Text] [Related]
19. The effects of calcium channel blockers, verapamil, nifedipine and diltiazem, on metabolic control in diabetic rats.
Kaymaz AA; Tan H; Altuğ T; Büyükdevrim AS
Diabetes Res Clin Pract; 1995 Jun; 28(3):201-5. PubMed ID: 8529499
[TBL] [Abstract][Full Text] [Related]
20. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
Hamm CW; Opie LH
Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
